• Open Access

Scientific Opinion on the substantiation of health claims related to EPA, DHA, DPA and maintenance of normal blood pressure (ID 502), maintenance of normal HDL-cholesterol concentrations (ID 515), maintenance of normal (fasting) blood concentrations of triglycerides (ID 517), maintenance of normal LDL-cholesterol concentrations (ID 528, 698) and maintenance of joints (ID 503, 505, 507, 511, 518, 524, 526, 535, 537) pursuant to Article 13(1) of Regulation (EC) No 1924/2006


  • EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

  • Panel members: Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Henk van den Berg, Hendrik van Loveren and Hans Verhagen
  • Correspondence: nda@efsa.europa.eu
  • Adoption date: 2 July 2009
  • Published date: 1 October 2009
  • Question number: EFSA-Q-2008-1289, EFSA-Q-2008-1290, EFSA-Q-2008-1292, EFSA-Q-2008-1294, EFSA-Q-2008-1298, EFSA-Q-2008-1302, EFSA-Q-2008-1304, EFSA-Q-2008-1305, EFSA-Q-2008-1311, EFSA-Q-2008-1313, EFSA-Q-2008-1315, EFSA-Q-2008-1322, EFSA-Q-2008-1324, EFSA-Q-2008-1485
  • On request from: European Commission